Home > News > Entry into Microlean consortium (EC)

Entry into Microlean consortium (EC)


Inngenia will support the MICROLEAN by advising on the development of the automation system and producing the automated system at the end to obtain histology samples for cancer detection. Inngenia will manufacture and sell the automation system to the Cellpath integrator (UK). The objective of Inngenia in this project is to apply its automation knowledge in new areas of work in order to diversify and open up new business opportunities that would allow introducing in this new sector. The aim of this project is to develop a prototype that can be used in health centres by radiotherapy for cancer at the time of the transaction. Therefore, this project will allow Inngenia to enter in a key sector which is aligned with the objectives of the company.